Cargando…

Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models

Structural changes and neuropathology in the hypothalamus have been suggested to contribute to the non-motor manifestations of Huntington’s disease (HD), a neurodegenerative disorder caused by an expanded cytosine-adenine-guanine (CAG) repeat in the huntingtin (HTT) gene. In this study, we investiga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dickson, Elna, Dwijesha, Amoolya Sai, Andersson, Natalie, Lundh, Sofia, Björkqvist, Maria, Petersén, Åsa, Soylu-Kucharz, Rana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671106/ https://www.ncbi.nlm.nih.gov/pubmed/36408416 http://dx.doi.org/10.3389/fnins.2022.1027269

Ejemplares similares

Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice
por: Dickson, Elna, et al.
Publicado: (2022)

Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
por: Henningsen, Jo B., et al.
Publicado: (2021)

IKKβ signaling mediates metabolic changes in the hypothalamus of a Huntington disease mouse model
por: Soylu-Kucharz, Rana, et al.
Publicado: (2022)

Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington’s disease
por: Soylu-Kucharz, Rana, et al.
Publicado: (2016)

Hypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue
por: Soylu-Kucharz, Rana, et al.
Publicado: (2015)

Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington’s disease R6/2 mice
por: Soylu-Kucharz, Rana, et al.
Publicado: (2017)

Expression of Mutant Huntingtin in Leptin Receptor-Expressing Neurons Does Not Control the Metabolic and Psychiatric Phenotype of the BACHD Mouse
por: Lundh, Sofia Hult, et al.
Publicado: (2012)

Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
por: Stan, Tiberiu Loredan, et al.
Publicado: (2020)

Maintenance of Basal Levels of Autophagy in Huntington’s Disease Mouse Models Displaying Metabolic Dysfunction
por: Baldo, Barbara, et al.
Publicado: (2013)

The Role of Hypothalamic Pathology for Non-Motor Features of Huntington’s Disease
por: Cheong, Rachel Y., et al.
Publicado: (2019)

Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice
por: Petersén, Åsa, et al.
Publicado: (2005)

Preserved blood-brain barrier and neurovascular coupling in female 5xFAD model of Alzheimer’s disease
por: Zhukov, Oleg, et al.
Publicado: (2023)

Abnormal peripheral chemokine profile in Huntington’s disease
por: Wild, Edward, et al.
Publicado: (2011)

Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington’s disease
por: Sjögren, Marie, et al.
Publicado: (2017)

Volumetric Analysis of the Hypothalamus in Huntington Disease Using 3T MRI: The IMAGE-HD Study
por: Gabery, Sanaz, et al.
Publicado: (2015)

Apolipoprotein M-bound sphingosine-1-phosphate regulates blood–brain barrier paracellular permeability and transcytosis
por: Mathiesen Janiurek, Mette, et al.
Publicado: (2019)

White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington’s Disease
por: McCourt, Andrew C., et al.
Publicado: (2016)

Oxytocin in Huntington’s disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia
por: Bergh, Sofia, et al.
Publicado: (2022)

A Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward
por: Silajdžić, Edina, et al.
Publicado: (2018)

Effects of mutant huntingtin inactivation on Huntington disease‐related behaviours in the BACHD mouse model
por: Cheong, Rachel Y., et al.
Publicado: (2021)

Centrally and peripherally altered glucose transporters: is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?
por: Björkqvist, Maria
Publicado: (2023)

Effects of Deletion of Mutant Huntingtin in Steroidogenic Factor 1 Neurons on the Psychiatric and Metabolic Phenotype in the BACHD Mouse Model of Huntington Disease
por: Baldo, Barbara, et al.
Publicado: (2014)

Altered Hypothalamic Protein Expression in a Rat Model of Huntington's Disease
por: Cong, Wei-na, et al.
Publicado: (2012)

Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington’s Disease
por: Duarte, Ana I., et al.
Publicado: (2018)

JAK/STAT Signalling in Huntington’s Disease Immune Cells
por: Träger, Ulrike, et al.
Publicado: (2013)

Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models
por: Träger, Ulrike, et al.
Publicado: (2015)

Correction: Altered Hypothalamic Protein Expression in a Rat Model of Huntington's Disease
por: Cong, Wei-na, et al.
Publicado: (2012)

Human α-synuclein overexpression in a mouse model of Parkinson’s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation
por: Elabi, Osama, et al.
Publicado: (2021)

A Metabolic Study of Huntington’s Disease
por: Nambron, Rajasree, et al.
Publicado: (2016)

Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism
por: Vercruysse, Pauline, et al.
Publicado: (2018)

Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice
por: Gil, Joana MAC, et al.
Publicado: (2004)

Hypothalamic Endocrine Tumors: An Update
por: Asa, Sylvia L., et al.
Publicado: (2019)

Serum levels of a subset of cytokines show high interindividual variability and are not altered in rats transgenic for Huntington´s disease
por: Nguyen, Huu Phuc, et al.
Publicado: (2010)

Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington's disease
por: Bartlett, Danielle M., et al.
Publicado: (2018)

A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease
por: Kalliolia, Eirini, et al.
Publicado: (2015)

Pro-fibrogenic and adipogenic aspects of chronic muscle degeneration are contributed by distinct stromal cell subpopulations
por: Özdemir, Cansu, et al.
Publicado: (2023)

Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease
por: Du, X, et al.
Publicado: (2012)

Environmental enrichment rescues female-specific hyperactivity of the hypothalamic-pituitary-adrenal axis in a model of Huntington's disease
por: Du, X, et al.
Publicado: (2012)

Characterization of Gastric Mucosa Biopsies Reveals Alterations in Huntington's Disease
por: McCourt, Andrew C, et al.
Publicado: (2015)

Components of the endocannabinoid and dopamine systems are dysregulated in Huntington's disease: analysis of publicly available microarray datasets
por: Laprairie, Robert B, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_44vlf67jt0bqt71ukls34pss9g